Drug Shortage Report for REPAGLINIDE
| Report ID | 35070 |
| Drug Identification Number | 02415968 |
| Brand name | REPAGLINIDE |
| Common or Proper name | REPAGLINIDE |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | REPAGLINIDE |
| Strength(s) | 0.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A10BX |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-11-15 |
| Estimated end date | |
| Actual end date | 2019-01-11 |
| Shortage status | Resolved |
| Updated date | 2019-01-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-01-05 | English | Compare |
| v2 | 2018-01-05 | French | Compare |
| v3 | 2018-02-13 | English | Compare |
| v4 | 2018-02-13 | French | Compare |
| v5 | 2018-03-20 | English | Compare |
| v6 | 2018-03-20 | French | Compare |
| v7 | 2018-03-26 | English | Compare |
| v8 | 2018-03-26 | French | Compare |
| v9 | 2018-04-03 | English | Compare |
| v10 | 2018-04-03 | French | Compare |
| v11 | 2018-11-15 | English | Compare |
| v12 | 2018-11-15 | French | Compare |
| v13 | 2018-11-16 | English | Compare |
| v14 | 2019-01-08 | English | Compare |
| v15 | 2019-01-08 | French | Compare |
| v16 | 2019-01-11 | English | Compare |
| v17 | 2019-01-11 | French | Compare |
| v18 | 2019-01-12 | English | Compare |
Showing 1 to 18 of 18